Carlsmed
-
Regulatory
FDA Grants Second Breakthrough Device Designation for Carlsmed Technology
CARLSBAD, Calif., September 20, 2023 — (BUSINESS WIRE)– Carlsmed announced today that the FDA granted Breakthrough Device designation for its…
Read More » -
Financial
Carlsmed Raises $30M in Series B Funding to Scale Personalized Spine Surgery
CARLSBAD, Calif.–/OrthoSpineNews/– Carlsmed announced today that it closed an oversubscribed $30M Series B funding round, led by B Capital Group,…
Read More »